PROVIDER PROFILE · NPI 1720378169
Cesar GuerreroMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
6,556
Unique beneficiaries
—
Total services
11,144
Distinct HCPCS
45
Medicare payment
$648K
Peer benchmark
Total Medicare services vs. 68 Dermatology providers in MS — top quintile (cohort median 4,925).
PRESCRIBING · PART D · 2024
Total Rx claims
1,390
Beneficiaries
—
Total drug cost
$136K
Distinct drugs
21
Brand share
5.6%
Top prescribed drugs
Triamcinolone Acetonide314 claims
Ketoconazole250 claims
Clobetasol Propionate218 claims
Hydrocortisone121 claims
Betamethasone Dipropionate64 claims
QUALITY · MIPS · 2024
Final MIPS score
98.3
Quality
96.7
Cost
92.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.98%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$281
Payment records
10
By payment type
Food and Beverage$281
Top paying entities
Food and Beverage$281
REFERRAL NETWORK
Where Cesar Guerrero's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | 367 | 1,416 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 20 | 41 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE